Company Description
Acorda Therapeutics hopes its products really get on your nerves. The company is developing therapeutics that would restore neurological function...
Key Acorda Therapeutics Financials
| Company Type | Public - NASDAQ (GM): ACOR Main Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2007 Sales (mil.) | $39.5 |
| 2005 Employees | 80 |
More Acorda Therapeutics Financials (8 pages)
Competition
Competitive Landscape for Biotechnology Sector
Demand often depends on the income of consumers or the profitability of business customers, because many technology products and services are expensive. The profitability of individual companies is...
Read more about Acorda Therapeutics's competition across multiple industries
Top Acorda Therapeutics Competitors
Sponsored Links
The Business Directory
Acorda Therapeutics Executives
| Title | Name & Bio | Contact |
|---|---|---|
| President CEO, and Director | Ron Cohen | Network | E-mail |
| CFO | David Lawrence | Network | E-mail |
| VP Business Development | Gerard A. Cignarella | Network | E-mail |
More Acorda Therapeutics Executives
| Are You Listed On Hoover's? | ||
|---|---|---|
| Hoover's subscribers also get access to information on people who have self-listed with this company. Subscribers also have the option to add themselves to this company record. |
Tools from our advertising partners:
Current Acorda Therapeutics News
- Acorda Therapeutics, Inc. (ACOR) Corporate Event Announcement Notice [Wall Street Horizon] (10 Oct 2008 20:37:00 EDT)
- Proteoglycan degrading mutants for the treatment of CNS [U.S. Patents] (09 Oct 2008 11:44:00 EDT)
- BioWorld Today September 23, 2008 [BioWorld Today] (23 Sep 2008 00:01:00 EDT)
Sponsored Opportunity
